Non Opioid Treatment for Experimental Dyspnea

• Status: Completed
• Trial end date: 2012-05-01
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of this protocol is to test the effects of the non opioid nefopam on experimental dyspnea and on the counterirritation (ie inhibition of one pain by another pain) induced by dyspnea in healthy subjects.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Assistance Publique - Hôpitaux de Paris
• Treatments: Analgesics, Non-Narcotic; Nefopam

Criteria

Inclusion Criteria:

• Healthy

• Non-smoking

Exclusion Criteria:

• acute or chronic pain

• antalgic or psychoactive drugs use

• nefopam hypersensibility

• severe allergy

• diabetes

• glaucoma

• prostate adenoma

• seizure disorder or convulsion history

• heart or circulation disease

• pulmonary disease or asthma

• kidney or liver disease

• brain or nerve disease

• lack of adhesion to no antalgic drug, alcohol, coffee and cola within previous experiment day consumption